Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DM1”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02314481
What this trial is testing

Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity

Who this might be right for
Non-small Cell Lung Cancer
University College, London 50
Not applicableUnknownNCT06029192
What this trial is testing

Diastolic Function in Myotonic Dystrophy Type 1

Who this might be right for
Diastolic Dysfunction
Centre d'Investigation Clinique et Technologique 805 500
Not applicableUnknownNCT02269865
What this trial is testing

Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Stanford University 40
Early research (Phase 1)Study completedNCT04509596
What this trial is testing

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Dizal Pharmaceuticals 23
Not applicableActive Not RecruitingNCT05072288
What this trial is testing

A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Université du Québec à Chicoutimi 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06185764
What this trial is testing

VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated 47
Large-scale testing (Phase 3)Looking for participantsNCT05004129
What this trial is testing

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

Who this might be right for
Congenital Myotonic Dystrophy
AMO Pharma Limited 76
Testing effectiveness (Phase 2)Study completedNCT01565200
What this trial is testing

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1

Who this might be right for
HER-2 Positive Breast Cancer
Jules Bordet Institute 90
Large-scale testing (Phase 3)UnknownNCT05848830
What this trial is testing

Home-based Training and Supplementation in DM1 Patients

Who this might be right for
Myotonic Dystrophy 1
McMaster University 60
Not applicableAvailableNCT07119775
What this trial is testing

Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy

Who this might be right for
Congenital Myotonic Dystrophy
AMO Pharma Limited
Not applicableStudy completedNCT05865483
What this trial is testing

Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)

Who this might be right for
Myotonic Dystrophy 1Dysphagia, Oropharyngeal
University College, London 177
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06926621
What this trial is testing

Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated 44
Testing effectiveness (Phase 2)Study completedNCT02312011
What this trial is testing

A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
Ionis Pharmaceuticals, Inc. 48
Large-scale testing (Phase 3)Active Not RecruitingNCT03975647
What this trial is testing

Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer 466
Early research (Phase 1)Study completedNCT00346255
What this trial is testing

BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
ImmunoGen, Inc. 37
Not applicableStudy completedNCT04712422
What this trial is testing

Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1

Who this might be right for
Myotonic Dystrophy 1
Istituto Auxologico Italiano 42
Testing effectiveness (Phase 2)Ended earlyNCT03709082
What this trial is testing

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast Cancer Metastatic
University of Kansas Medical Center 3
Not applicableStudy completedNCT04001920
What this trial is testing

Effects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Cynthia Gagnon 11
Not applicableActive Not RecruitingNCT05889988
What this trial is testing

Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

Who this might be right for
Breast Neoplasm
Mayo Clinic 36
Not applicableStudy completedNCT04634682
What this trial is testing

Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Myogem Health Company, S.L. 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation